Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Arman Haghighi

Dentist, Oral and Maxillofacial Surgery Boise, ID Doctor of Dentistry

NPI 1124433743 CMS profile 709122

403 S 11Th St Ste 300, Boise, ID 83702

Open in the dashboard

General payments

$11,325

108 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Arman Haghighi of Boise, ID is reported in the CMS Open Payments database as having received $11,325 across 108 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,036 20
2024 General $1,371 23
2023 General $687 17
2022 General $784 16
2021 General $6,637 17
2020 General $268 7
2019 General $542 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Arman Haghighi
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Arman Haghighi were reported at $1,036. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Arman Haghighi Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $542 $142 $50–$420 $163
2020 $268 $96 $36–$277 $114
2021 $6,637 $138 $45–$419 $132
2022 $784 $144 $48–$367 $149
2023 $687 $153 $55–$399 $160
2024 $1,371 $152 $50–$400 $164
2025 $1,036 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $8,680 63 payments
  2. KLS-Martin L.P. $1,230 15 payments
  3. Nobel Biocare USA $307 7 payments
  4. Zimmer Biomet Holdings, Inc. $291 6 payments
  5. Hu-Friedy Mfg. Co., LLC $283 3 payments
  6. Allergan Inc. $181 3 payments
  7. Stryker Corporation $135 3 payments
  8. Henry Schein, Inc. $62 2 payments
  9. Dentsply Sirona Inc $45 2 payments
  10. Zimvie Inc. $38 1 payment
  11. Other $73 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Gift $6,174 9 payments
  2. Food and Beverage $4,262 91 payments
  3. Education $658 5 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $231 3 payments
Products named General payments · program years 2019–2025
  1. Hu-Friedy Mfg. Co., LLC $261 2 payments
  2. NOBELACTIVE Dental implant $144 3 payments
  3. Dental Product Portfolio $109 2 payments
  4. NOBELREPLACE $95 3 payments
  5. NOBELPARALLEL $95 3 payments
  6. NOBELACTIVE Dental implant $95 3 payments
  7. NOBELPROCERA $95 3 payments
  8. NOBELSPEEDY $95 3 payments
  9. Puros $90 2 payments
  10. BOTOX COSMETIC $84 1 payment
  11. Other $435 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

889

Median for Oral Surgery (Dentist only): 288

Drug cost

$4,629

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

41.4%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ondansetron Odt Ondansetron Brand 144 $1,355
Chlorhexidine Gluconate Generic 285 $994
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 193 $826
Amoxicillin Generic 189 $488
Clindamycin Hcl Generic 36 $426
Moxifloxacin Hcl Generic 11 $284
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 31 $255

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$6,770

Medicare's payments for the services billed

Medicare patients

34

Average age 74

Services billed

86

18 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 56%
Arthritis 47%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record